Pancreatic Cancer Archive - Seite 7 von 11 - IOZK

A feasibility and safety study of vaccination with poly-ICLC and peptide-pulsed dendritic cells in patients with metastatic, locally advanced unresectable, or recurrent pancreatic adenocarcinoma.

2014-05-30/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2014-05-30 / J Clin Oncol 32, 2014 (suppl; abstr e15254)

Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis

2014-04-29/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2014-04-29 / Cancer Immunol. Immunother. 2014 Aug;63(8):797-806

Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection

2014-01-03/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2014-01-03 / Cancer Gene Ther. 2014 Jan;21(1):24-30

Phase II study of dendritic cell vaccination combined with recombinant adenovirus-p53 in treatment for patients with advanced pancreatic carcinoma.

2013-06-03/in Dendritic Cells, Pancreatic Cancer /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3049)

Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma

2013-04-19/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2013-04-19 / Cancer Immunol. Immunother. 2013 Jun;62(6):1083-91

Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer

2012-12-17/in Hyperthermia, International Publications, Pancreatic Cancer /von 2012-12-17 / Int J Hyperthermia 2013;29(1):8-16

Two avirulent, lentogenic strains of Newcastle disease virus are cytotoxic for some human pancreatic tumor lines in vitro

2012-09-10/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2012-09-10 / JOP 2012 Sep;13(5):502-13

Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma

2012-08-01/in Hyperthermia, International Publications, Pancreatic Cancer /von 2012-08-01 / J. Cell. Mol. Med. 2012 Aug;16(8):1776-91

Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer

2012-07-27/in Hyperthermia, International Publications, Pancreatic Cancer /von 2012-07-27 / Int J Hyperthermia 2012;28(7):597-604

Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma

2012-03-01/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2012-03-01 / Pancreas 2012 Mar;41(2):195-205